104 related articles for article (PubMed ID: 11362028)
1. CSF replication reduced with Sustiva.
AIDS Patient Care STDS; 1998 Oct; 12(10):802. PubMed ID: 11362028
[No Abstract] [Full Text] [Related]
2. [DuPont-Pharma Laboratories. Sustiva].
Allerg Immunol (Paris); 1998 Nov; 30(9):302. PubMed ID: 9887991
[No Abstract] [Full Text] [Related]
3. DMP 266 and indinavir combination.
AIDS Patient Care STDS; 1997 Aug; 11(4):287-8. PubMed ID: 11361845
[No Abstract] [Full Text] [Related]
4. New study shows efavirenz effective with d4T and 3TC.
AIDS Alert; 1999 May; 14(5):60. PubMed ID: 11366404
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy.
Tashima KT; Caliendo AM; Ahmad M; Gormley JM; Fiske WD; Brennan JM; Flanigan TP
J Infect Dis; 1999 Sep; 180(3):862-4. PubMed ID: 10438381
[TBL] [Abstract][Full Text] [Related]
6. Rapid decay of HIV RNA in the cerebrospinal fluid during antiretroviral combination therapy.
Stellbrink HJ; Eggers C; van Lunzen J; Albrecht H; Greten H
AIDS; 1997 Nov; 11(13):1655-7. PubMed ID: 9365775
[No Abstract] [Full Text] [Related]
7. [FDA approval of the first HIV anti-retroviral from DuPont-Pharma: SUSTIVA (efavirenz). SUSTIVA should be associated with other anti-retrovirals and could be considered a new alternative first line treatment].
Allerg Immunol (Paris); 1998 Oct; 30(8):268-70. PubMed ID: 9846197
[No Abstract] [Full Text] [Related]
8. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
[TBL] [Abstract][Full Text] [Related]
9. Mutations associated with hypersusceptibility...and with good adherence.
Barfod TS
J Infect Dis; 2004 Dec; 190(11):2056-7; author reply 2057. PubMed ID: 15529273
[No Abstract] [Full Text] [Related]
10. HIV encephalitis in a patient on antiretroviral therapy: a case report.
Hlebowicz M; Parczewski M; Jakubowski P
Int J STD AIDS; 2019 May; 30(6):617-619. PubMed ID: 30722753
[TBL] [Abstract][Full Text] [Related]
11. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
[No Abstract] [Full Text] [Related]
12. Viral escape in cerebrospinal fluid--an achilles heel of HIV therapy?
Clifford DB
J Infect Dis; 2010 Dec; 202(12):1768-9. PubMed ID: 21050117
[No Abstract] [Full Text] [Related]
13. [Decrease of HIV-1 virus load by nevirapin/efavirenz].
Dtsch Med Wochenschr; 2003 May; 128(19):1075. PubMed ID: 12774797
[No Abstract] [Full Text] [Related]
14. Sustiva granted full FDA approval.
AIDS Read; 2000 Mar; 10(3):147. PubMed ID: 10798886
[No Abstract] [Full Text] [Related]
15. Cerebrospinal fluid viral loads reach less than 2 copies/ml in HIV-1-infected patients with effective antiretroviral therapy.
Yilmaz A; Svennerholm B; Hagberg L; Gisslén M
Antivir Ther; 2006; 11(7):833-7. PubMed ID: 17302245
[TBL] [Abstract][Full Text] [Related]
16. Sustiva added to three-drug combination.
AIDS Patient Care STDS; 1998 Oct; 12(10):803. PubMed ID: 11362030
[No Abstract] [Full Text] [Related]
17. Efficacy of nelfinavir-based treatment in the central nervous system of HIV-1 infected patients.
Karlström O; Ståhle L; Perrin L; Tegude H; Sönnerborg A
Scand J Infect Dis; 2006; 38(5):371-4. PubMed ID: 16709540
[TBL] [Abstract][Full Text] [Related]
18. Don't mix Sustiva with Fortovase.
Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
[TBL] [Abstract][Full Text] [Related]
19. DuPont initiates Sustiva oral liquid expanded access program.
AIDS Read; 2000 Jun; 10(6):339. PubMed ID: 10881361
[No Abstract] [Full Text] [Related]
20. Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid.
van Lelyveld SF; Nijhuis M; Baatz F; Wilting I; van den Bergh WM; Kurowski M; de Jong D; Hoepelman AI; Wensing AM
Clin Infect Dis; 2010 Feb; 50(3):387-90. PubMed ID: 20047481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
